ESP Oral Abstract Session
Friday, September 6, 2024 09:15 AM - 10:15 AM
F3
Oral Abstracts
Co-Chairs:
Included Abstracts:
- Vincenzo Di Cerbo, PhD, Cell and Gene Therapy Catapult, United Kingdom
- Amina Agovic, MSc, CCRM Nordic, Sweden
Included Abstracts:
- Takahiro Asatsuma, MSc, The Peter Doherty Institute for Infection and Immunity, Australia - Defining genetic factor controlling CD4+ T cell differentiation in vivo during blood-stage malaria infection
- Laura Baqué Vidal, MSc, PhD, Karolinska Institutet, Karolinska Universitetsjukhuset i Huddinge, Sweden - Manufacture, preclinical quality, safety and efficacy of CellThRPE1, a human embryonic stem cell-derived retinal pigment epithelial cell product for the treatment of dry age-related retinal degeneration
- Agner Henrique Dorigo Hochuli, MSc, Universita degli Studi di Padova, Institute of Paediatric Research Città della Speranza, Italy - Inflammatory bowel disease induced colon organoids treated with Extracellular Vesicles engineered with microRNA-31 show regeneration
- Víctor Garcia-Gragera, MSc, Universitat Ramon Llull IQS, Banc de Sang i Teixits, Spain - Optimized hWJ-MSC Colonization in microcarrier-based Stirred Tank Bioreactors using Design of Experiments
- Rahim Hirani, MS, New York Medical College School of Medicine, New York Medical College Graduate School of Basic Medical Sciences, Westchester Medical Center, United States - Alleviating RDEB Complications Through Stem Cell Therapy: The Role of Unrestricted Somatic Stem Cells in Modulating Inflammation and Fibrosis
- Pierre Springuel, PhD, University College London, United Kingdom – Towards scalable, high-yield CAR-T manufacturing: optimisation of a multi-litre perfusion bioprocess in stirred-tank bioreactors with automated downstream cell harvesting
